
Leonard Glass
doctorMale0.0Global Dominance: 0.00%
Dr. Leonard Glass serves as the Senior Vice President of Global Medical Affairs at Eli Lilly, where he oversees research and development in pharmacological treatments. He expressed satisfaction with the results of a recent clinical trial showing that Munjaro led to significantly greater weight loss compared to its competitor, Wegovy, positioning it as a leading treatment option for obesity.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Leonard Glass is the senior vice president of global medical affairs at Lilly and commented on the effectiveness of tirzepatida for treating obesity.
Estudo compara perda de peso de pacientes com obesidade tratados com Mounjaro e Wegovy; veja dadosO Estado de S. Paulo (Estadão)·
Liechtenstein· 2025-05-13
Also mentioned
Fabio Trujilho

Dr. Leonard Glass expressed satisfaction with the data from the comparative study on Monjaro.
זריקת הרזיה במבחן: מונג'רו או וויגוביידיעות אחרונות (Yedioth Ahronoth / ynet)·
Israel· 2025-05-12
Also mentioned
Luis J Aron
